Devyser Diagnostics AB Buyback Yield % Related Terms
Devyser Diagnostics AB Buyback Yield % Historical Data
* Premium members only.
The historical data trend for Devyser Diagnostics AB's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:OL0 vs ABT, SYK, MDT: Buyback Yield % Comparison
For the Medical Devices subindustry, Devyser Diagnostics AB's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Devyser Diagnostics AB Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Devyser Diagnostics AB's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Devyser Diagnostics AB's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Devyser Diagnostics AB (FRA:OL0) has a Buyback Yield % of -1.01 as of Jul. 09, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Devyser Diagnostics AB and its competitors. According to the industry distribution chart, Devyser Diagnostics AB ranks #186 out of 346 companies in the Medical Devices & Instruments industry, placing it in the top 53.8%.
Is Devyser Diagnostics AB's Buyback Yield % too high?
Devyser Diagnostics AB's current Buyback Yield % is -1.01. Based on the distribution chart, Devyser Diagnostics AB ranks #186 out of 346 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Devyser Diagnostics AB has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Devyser Diagnostics AB's Buyback Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Devyser Diagnostics AB ranks #186 out of 346 companies for Buyback Yield %. This places Devyser Diagnostics AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Devyser Diagnostics AB and its competitors. Devyser Diagnostics AB's current Buyback Yield % is -1.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Devyser Diagnostics AB stock overvalued right now?
Based on GuruFocus' analysis, Devyser Diagnostics AB (FRA:OL0) is currently considered Significantly Undervalued. The stock's GF Value™ is €14.13, compared to a current price of €5.49 — trading 61.1% below its estimated fair value. The current Buyback Yield % is -1.01. Devyser Diagnostics AB's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Devyser Diagnostics AB (FRA:OL0), the current Buyback Yield % is -1.01 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Devyser Diagnostics AB (FRA:OL0) Overvalued in 2026?
Based on GuruFocus' analysis, Devyser Diagnostics AB stock appears to be undervalued.
The current stock price of €5.49 is trading 61.1% below its estimated GF Value™ of €14.13.
GuruFocus considers Devyser Diagnostics AB to be Significantly Undervalued.
Key valuation signals for FRA:OL0:
Buyback Yield %: -1.01
GF Value™: €14.13 vs. price of €5.49 (61.1% below fair value)
No single metric tells the full story. See the FRA:OL0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Devyser Diagnostics AB is engaged in the development, manufacture, and sale of kits for genetic testing in routine diagnostic laboratories. The products are used for advanced genetic testing in the hereditary disease, oncology, and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.
71GF Score
Get the complete analysis for FRA:OL0
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:OL0 has been successfully added to your 
